{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:25Z","timestamp":1793306005805,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.psyneuen.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T11:06:25Z","timestamp":1415444785000},"page":"585-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":286,"special_numbering":"C","title":["The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study"],"prefix":"10.1016","volume":"51","author":[{"given":"Rakesh","family":"Jetly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Heber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Boisvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.psyneuen.2014.11.002_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","article-title":"Best practice guide for the treatment of nightmare disorder in adults","volume":"6","author":"Aurora","year":"2010","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for PTSD related insomnia and nightmares, chronic pain, harm reduction and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jat\/13.4.240","article-title":"Lack of interference by nabilone in the EMIT d.a.u. cannabinoid assay, Abbott TDx cannabinoid assay, and a sensitive TLC assay for delta 9-THC-carboxilic acid","volume":"13","author":"Fraser","year":"1989","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1176\/appi.ajp.2013.13060768","article-title":"Toward rational pharmacotherapy for posttraumatic stress disorder: reprise","volume":"170","author":"Friedman","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jclp.20730","article-title":"Treatment of nightmares in the context of posttraumatic stress disorder","volume":"66","author":"Gehrman","year":"2010","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00023210-200620070-00003","article-title":"Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management","volume":"20","author":"Maher","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2011.02.029","article-title":"Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence","volume":"62","author":"Nappi","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1360-0443.2009.02776.x","article-title":"The abuse potential of the synthetic cannabinoid nabilone","volume":"105","author":"Ware","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0075","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00415-006-0218-8","article-title":"Low dose treatment with the synthetic cannabinoid nabilone significantly reduces spasticity-related pain: a double-blind placebo-controlled cross-over trial","volume":"253","author":"Wissel","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.psyneuen.2014.11.002_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000096362","article-title":"Dreaming in posttraumatic stress disorder: a critical review of phenomenology, psychophysiology and treatment","volume":"76","author":"Wittmann","year":"2007","journal-title":"Psychother. Psychosom."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:52:51Z","timestamp":1759683171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453014004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":13,"alternative-id":["S0306453014004132"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.002","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}